[Skip to Content]
[Skip to Content Landing]
Article
June 1990

Krypton Laser Photocoagulation for Neovascular Lesions of Age-Related Macular DegenerationResults of a Randomized Clinical Trial

Arch Ophthalmol. 1990;108(6):816-824. doi:10.1001/archopht.1990.01070080058036
Abstract

• The Age-Related Macular Degeneration Study-Krypton Laser (AMDS-K) is a multicenter controlled clinical trial designed to determine whether krypton red laser photocoagulation is of value in preventing visual acuity loss in eyes with macular degeneration that have either choroidal neovascularization 1 to 199 μm from the center of the foveal avascular zone or choroidal neovascularization 200 μm or farther from the foveal avascular zone center with blood and/or blocked fluorescence extending within 200 μm of the foveal avascular zone center. Recruitment ended in December 1987 after 247 patients had been assigned to photocoagulation and 249 patients had been assigned to no treatment. At 3 years after randomization, 49% (86/174) of treated eyes, in contrast to 58% (98/169) of untreated eyes, had lost six or more lines of visual acuity. The average visual acuity of treated and untreated eyes at that time was 20/200 and 20/250, respectively. The benefit of laser treatment was largest among patients without evidence of hypertension and diminished to no apparent benefit among patients who had highly elevated blood pressure and/or used antihypertensive medication. Treatment of lesions meeting the AMDS-K eligibility criteria in eyes of patients with no hypertension is recommended. However, treatment cannot be recommended uniformly for patients with definite hypertension having lesions similar to those of patients enrolled in the AMDS-K.

References
1.
Macular Photocoagulation Study Group.  Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial . Arch Ophthalmol . 1982;100:912-918.Article
2.
Bressler NM, Bressler SB, Gragoudas ES.  Clinical characteristics of choroidal neovascular membranes . Arch Ophthalmol . 1987;105:209-213.Article
3.
Bird AC, Grey RHB.  Photocoagulation of disciform macular lesions with krypton laser . Br J Ophthalmol . 1979;63:669-673.Article
4.
Marshall J, Bird AC.  A comparative histopathological study of argon and krypton laser irradiations of the human retina . Br J Ophthalmol . 1979;63:657-668.Article
5.
Peyman GA, Li M, Yoneya S, Goldberg MF, Raichand M.  Fundus photocoagulation with the argon and krypton lasers: a comparative study . Ophthalmic Surg . 1981;12:481-490.
6.
Macular Photocoagulation Study Group.  Argon laser photocoagulation for ocular histoplasmosis: results of a randomized clinical trial . Arch Ophthalmol . 1983;101:1347-1357.Article
7.
Macular Photocoagulation Study Group.  Argon laser photocoagulation for neovascular maculopathy: three-year results from randomized clinical trials . Arch Ophthalmol . 1986;104:694-701.Article
8.
Macular Photocoagulation Study Group.  Argon laser photocoagulation for idiopathic neovascularization: results of a randomized clinical trial . Arch Ophthalmol . 1983;101:1358-1361.Article
9.
Macular Photocoagulation Study Group.  Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy . Arch Ophthalmol . 1986;104:503-512.Article
10.
Macular Photocoagulation Study Group.  Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis: results of a randomized trial . Arch Ophthalmol . 1987;105:1499-1507.Article
11.
Macular Photocoagulation Study Group.  Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis . Arch Ophthalmol . 1989;107:344-352.Article
12.
Chamberlin JA, Bressler NM, Bressler SB, et al.  The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study . Ophthalmology . 1989;96:1526-1534.Article
13.
Macular Photocoagulation Study Group. Manual of Procedures . Springfield, Va: National Technical Information Service; April 1987. Accession No. PB87-221834.
14.
Bailey IL, Lovie JE.  New design principles for visual acuity letter charts . Am J Optom Physiol Optic . 1976;53:740-745.Article
15.
Brod J, Hilleboe HE, Kimura N, et al. Arterial Hypertension and Ischaemic Heart Disease: Preventive Aspects: Report of an Expert Committee . Geneva, Switzerland: World Health Organization; 1962. Technical Report Series No. 231.
16.
Hillis A, Maguire M, Hawkins BS, New-house MM.  The Markov process as a general method for nonparametric analysis of right-censored medical data . J Chron Dis . 1986;39:595-604.Article
17.
Zeger SL, Liang KY.  Longitudinal data analysis for discrete and continuous outcomes . Biometrics . 1986;42:121-130.Article
18.
Armitage P, Berry G. Statistical Methods in Medical Research . 2nd ed. Boston, Mass: Blackwell Scientific Publications Inc; 1987:372-374.
19.
Macular Photocoagulation Study Group.  Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration . Arch Ophthalmol . 1990;108:825-831.Article
20.
Macular Photocoagulation Study Group. Krypton Study Data Forms . Springfield, Va: National Technical Information Service; 1987. Accession No. PB87-221859.
21.
Macular Photocoagulation Study Group. Data Monitoring Report . Springfield, Va: National Technical Information Service; April 10, 1989. Accession No. PB90-122136.
×